Psychopharmacological profile of molindone.
D006916:5-Hydroxytryptophan / Q000494:pharmacology; D000661:Amphetamine / Q000037:antagonists & inhibitors; D000818:Animals; D001058:Apomorphine / Q000037:antagonists & inhibitors; D001362:Avoidance Learning / Q000187:drug effects; D001522:Behavior, Animal / Q000187:drug effects*; D002415:Cats; D002746:Chlorpromazine / Q000494:pharmacology; D003864:Depression, Chemical; D004295:Dihydroxyphenylalanine / Q000494:pharmacology; D004285:Dogs; D005260:Female; D000882:Haplorhini; D007211:Indoles / Q000494:pharmacology*; D008124:Locomotion / Q000187:drug effects; D008297:Male; D051379:Mice; D009025:Morpholines / Q000494:pharmacology*; D051381:Rats; D013747:Tetrabenazine / Q000037:antagonists & inhibitors
D007211:Indoles; D009025:Morpholines; D004295:Dihydroxyphenylalanine; D006916:5-Hydroxytryptophan; D000661:Amphetamine; D001058:Apomorphine; D002746:Chlorpromazine; D013747:Tetrabenazine